PC
Paulson & Co’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,450,000
| Closed | -$43.1M | – | 59 |
|
|
2017
Q3 | $43.1M | Sell |
2,450,000
-4,294,000
| -64% | -$75.6M | 0.77% | 25 |
|
|
2017
Q2 | $224M | Sell |
6,744,000
-4,253,300
| -39% | -$141M | 3.03% | 12 |
|
|
2017
Q1 | $353M | Sell |
10,997,300
-4,928,500
| -31% | -$158M | 4.68% | 5 |
|
|
2016
Q4 | $577M | Sell |
15,925,800
-151,100
| -0.9% | -$5.48M | 7.28% | 4 |
|
|
2016
Q3 | $740M | Sell |
16,076,900
-696,900
| -4% | -$32.1M | 8.02% | 4 |
|
|
2016
Q2 | $843M | Sell |
16,773,800
-3,828,400
| -19% | -$192M | 8.56% | 4 |
|
|
2016
Q1 | $1.1B | Buy |
20,602,200
+192,900
| +0.9% | +$10.3M | 8.15% | 3 |
|
|
2015
Q4 | $1.34B | Buy |
20,409,300
+2,409,300
| +13% | +$158M | 8.01% | 4 |
|
|
2015
Q3 | $1.02B | Buy |
18,000,000
+15,969,500
| +786% | +$902M | 5.28% | 6 |
|
|
2015
Q2 | $120M | Buy |
+2,030,500
| New | +$120M | 0.55% | 31 |
|